We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cardiac Hydrogel Delivered by Catheter Speeds Recovery in Porcine Heart Attack Model

By LabMedica International staff writers
Posted on 08 Mar 2012
A hydrogel derived from decellularized heart connective tissue was shown in both rat and porcine models to effectively aid in recovery from damage caused by myocardial infarction (MI).

Investigators at the University of California, San Diego (USA) prepared a novel hydrogel from cardiac connective tissue that was stripped of heart muscle cells through a cleansing process, freeze-dried and milled into powder form, and then liquefied into a fluid. More...
This substance was an injectable liquid at room temperature but turned into a semi-solid, porous gel at body temperature.

Rats were injected with the hydrogel or a saline control two weeks after having experienced induced MI. The implantation response was assessed via histology and immunohistochemistry, and the potential for development of arrhythmias was examined using programmed electrical stimulation one week after the injection. Cardiac function was analyzed with magnetic resonance imaging one week following the injection and four weeks following the MI. In the porcine MI model, the hydrogel was administered via a catheter.

Results published in the February 21, 2012, issue of the Journal of the American College of Cardiology revealed that injection of the material in the rat MI model increased endogenous cardiomyocytes in the infarct area and maintained cardiac function without inducing arrhythmias. Similar results were obtained in the porcine model, which demonstrated the feasibility of treatment by transendocardial catheter injection.

“It helps to promote a positive remodeling-type response, not a pro-inflammatory one in the damaged heart,” said senior author Dr. Karen Christman, professor of bioengineering at the University of California, San Diego. “Most of the materials that people have looked at have been tested in rats or mice, and they are injectable via a needle and syringe. However, almost all of them are not compatible with catheter delivery and would gel too quickly, clogging the catheter during the procedure.”

Related Links:
University of California, San Diego


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.